Rauzan, M., Chuah, C. T. H., Ko, T. K., & Ong, S. T. (2017). The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia. PLoS One.
シカゴスタイル引用形Rauzan, Muhammad, Charles T. H. Chuah, Tun Kiat Ko, , S. Tiong Ong. "The HDAC Inhibitor SB939 Overcomes Resistance to BCR-ABL Kinase Inhibitors Conferred By the BIM Deletion Polymorphism in Chronic Myeloid Leukemia." PLoS One 2017.
MLA引用形式Rauzan, Muhammad, Charles T. H. Chuah, Tun Kiat Ko, , S. Tiong Ong. "The HDAC Inhibitor SB939 Overcomes Resistance to BCR-ABL Kinase Inhibitors Conferred By the BIM Deletion Polymorphism in Chronic Myeloid Leukemia." PLoS One 2017.
警告: この引用は必ずしも正確ではありません.